Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cellular target of new antitumor agent from Nippon Shinyaku identified

Oct. 24, 1997

Nikken presents new modulator of multidrug resistance

Oct. 24, 1997

New DC-107 derivative presented at cancer meeting

Oct. 24, 1997

New antimitotic agents presented by Kyowa Hakko

Oct. 24, 1997

Improved DNA topoisomerase poisons discovered at Rutgers

Oct. 24, 1997

VEGF inhibitors described by Zeneca

Oct. 24, 1997

Dusa reports positive phase III results for Levulan PDT

Oct. 24, 1997

Preclinical results with L-methioninase presented at cancer meeting

Oct. 23, 1997

Antiproliferative quinazoline derivatives disclosed at Zeneca

Oct. 23, 1997

NeoPharm moves LED to phase I for prostate cancer

Oct. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...